Skip to main content
SpringerLink
Log in

Therapy of experimental influenza virus infection with pyrrolidine dithiocarbamate

  • Original Investigation
  • Published:
Medical Microbiology and Immunology Aims and scope Submit manuscript

Abstract

The search for new antiviral strategies to treat influenza A virus (IAV) infections is one major international health care activity. Hereby, the IAV-caused misuse of cellular nuclear factor kappa B (NF-κB) signaling pathways in infected cells represents one target for antiviral therapy. In the present study, pyrrolidine dithiocarbamate (PDTC), which is known as an antioxidant and as an inhibitor of IAV-induced NF-κB activation, was studied in vivo. After the antiviral activity of PDTC was confirmed in MDCK cells, mice—infected with the mouse-adapted strain of IAV A/PR/8/34 (H1N1)—were treated intraperitoneally simultaneously with PDTC (75, 150, 200 mg/kg body weight). The influence of PDTC administrations was evaluated on viral replication and inflammatory reactions in lung tissue up to 14 days postinfection (p. i.). This therapy increased survival up to 80% and reduced IAV-caused weight loss and viral replication in lung tissue in a dose-dependent manner. Protective effects were less pronounced, if the therapy started later on during an ongoing IAV infection. In addition, simultaneous PDTC treatment also limited IAV-caused infiltration of immune cells as well as local interferon-γ expression in lung tissue. These results imply that PDTC decreases IAV-caused disease in mice significantly. Therefore, the development of drugs like PDTC that interfere with NF-κB signaling may represent a modern focus of anti-IAV therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Taubenberger JK, Kash JC (2010) Influenza virus evolution, host adaptation, and pandemic formation. Cell Host Microbe 7(6):440–451

    Article  PubMed  CAS  Google Scholar 

  2. Taubenberger JK, Morens DM (2010) Influenza: the once and future pandemic. Public Health Rep 125(Suppl 3):16–26

    PubMed  Google Scholar 

  3. Krug RM, Aramini JM (2009) Emerging antiviral targets for influenza A virus. Trends Pharmacol Sci 30(6):269–277

    Article  PubMed  CAS  Google Scholar 

  4. Lin C, Zimmer SG, Lu Z, Holland RE Jr, Dong Q, Chambers TM (2001) The involvement of a stress-activated pathway in equine influenza virus-mediated apoptosis. Virology 287(1):202–213

    Article  PubMed  CAS  Google Scholar 

  5. Morris SJ, Price GE, Barnett JM, Hiscox SA, Smith H, Sweet C (1999) Role of neuraminidase in influenza virus-induced apoptosis. J Gen Virol 80:137–146

    PubMed  CAS  Google Scholar 

  6. Takizawa T, Matsukawa S, Higuchi Y, Nakamura S, Nakanishi Y, Fukuda R (1993) Induction of programmed cell death (apoptosis) by influenza virus infection in tissue culture cells. J Gen Virol 74:2347–2355

    Article  PubMed  CAS  Google Scholar 

  7. Uchide N, Ohyama K, Bessho T, Yuan B, Yamakawa T (2002) Effect of antioxidants on apoptosis induced by influenza virus infection: inhibition of viral gene replication and transcription with pyrrolidine dithiocarbamate. Antiviral Res 56(3):207–217

    Article  PubMed  CAS  Google Scholar 

  8. Miyamoto D, Kusagaya Y, Endo N, Sometani A, Takeo S, Suzuki T, Arima Y, Nakajima K, Suzuki Y (1998) Thujaplicin-copper chelates inhibit replication of human influenza viruses. Antiviral Res 39(2):89–100

    Article  PubMed  Google Scholar 

  9. Uchide N, Ohyama K, Bessho T, Yuan B, Yamakawa T (2002) Apoptosis in cultured human fetal membrane cells infected with influenza virus. Biol Pharm Bull 25(1):109–114

    Article  PubMed  CAS  Google Scholar 

  10. Shi XL, Shi ZH, Huang H, Zhu HG, Zhou P, Ju D (2010) Therapeutic effect of recombinant human catalase on H1N1 influenza-induced pneumonia in mice. Inflammation 33(3):166–172

    Article  PubMed  CAS  Google Scholar 

  11. Knobil K, Choi AM, Weigand GW, Jacoby DB (1998) Role of oxidants in influenza virus-induced gene expression. Am J Physiol 274:134–142

    Google Scholar 

  12. Lowy RJ, Dimitrov DS (1997) Characterization of influenza virus-induced death of J774.1 macrophages. Exp Cell Res 234(2):249–258

    Article  PubMed  CAS  Google Scholar 

  13. Olsen CW, Dybdahl-Sissoko N, Hinshaw VS (1996) The influence of calcium and reactive oxygen species on influenza virus-induced apoptosis. Cell Death Differ 3(2):191–197

    PubMed  CAS  Google Scholar 

  14. Meyer M, Schreck R, Baeuerle PA (1993) H2O2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J 12(5):2005–2015

    PubMed  CAS  Google Scholar 

  15. Schreck R, Meier B, Mannel DN, Droge W, Baeuerle PA (1992) Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med 175(5):1181–1194

    Article  PubMed  CAS  Google Scholar 

  16. Hayakawa M, Miyashita H, Sakamoto I, Kitagawa M, Tanaka H, Yasuda H, Karin M, Kikugawa K (2003) Evidence that reactive oxygen species do not mediate NF-kappa B activation. EMBO J 22(13):3356–3366

    Article  PubMed  CAS  Google Scholar 

  17. Kim I, Kim CH, Kim JH, Lee J, Choi JJ, Chen ZA, Lee MG, Chung KC, Hsu CY, Ahn YS (2004) Pyrrolidine dithiocarbamate and zinc inhibit proteasome-dependent proteolysis. Exp Cell Res 298(1):229–238

    Article  PubMed  CAS  Google Scholar 

  18. Borrello S, Demple B (1997) NF kappa B-independent transcriptional induction of the human manganous superoxide dismutase gene. Arch Biochem Biophys 348(2):289–294

    Article  PubMed  CAS  Google Scholar 

  19. Hartsfield CL, Alam J, Choi AM (1998) Transcriptional regulation of the heme oxygenase 1 gene by pyrrolidine dithiocarbamate. FASEB J 12(15):1675–1682

    PubMed  CAS  Google Scholar 

  20. Wild AC, Mulcahy RT (1999) Pyrrolidine dithiocarbamate up-regulates the expression of the genes encoding the catalytic and regulatory subunits of gamma-glutamylcysteine synthetase and increases intracellular glutathione levels. Biochem J 338:659–665

    Article  PubMed  CAS  Google Scholar 

  21. Uchide N, Ohyama K, Bessho T, Toyoda H (2005) Inhibition of influenza-virus-induced apoptosis in chorion cells of human fetal membranes by nordihydroguaiaretic Acid. Intervirology 48(5):336–340

    Article  PubMed  CAS  Google Scholar 

  22. Uchide N, Ohyama K (2003) Antiviral function of pyrrolidine dithiocarbamate against influenza virus: the inhibition of viral gene replication and transcription. J Antimicrob Chemother 52(1):8–10

    Article  PubMed  CAS  Google Scholar 

  23. Flory E, Kunz M, Scheller C, Jassoy C, Stauber R, Rapp UR, Ludwig S (2000) Influenza virus-induced NF-kappa B-dependent gene expression is mediated by overexpression of viral proteins and involves oxidative radicals and activation of Ikappa B kinase. J Biol Chem 275(12):8307–8314

    Article  PubMed  CAS  Google Scholar 

  24. Nimmerjahn F, Dudziak D, Dirmeier U, Hobom G, Riedel A, Schlee M, Staudt LM, Rosenwald A, Behrends U, Bornkamm GW, Mautner J (2004) Active NF-kappa B signalling is a prerequisite for influenza virus infection. J Gen Virol 85:2347–2356

    Article  PubMed  CAS  Google Scholar 

  25. Wurzer WJ, Ehrhardt C, Pleschka S, Berberich-Siebelt F, Wolff T, Walczak H, Planz O, Ludwig S (2004) NF-kappa B-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas/FasL is crucial for efficient influenza virus propagation. J Biol Chem 279(30):30931–30937

    Article  PubMed  CAS  Google Scholar 

  26. Schmolke M, Viemann D, Roth J, Ludwig S (2009) Essential impact of NF-kappaB signaling on the H5N1 influenza A virus-induced transcriptome. J Immunol 183(8):5180–5189

    Article  PubMed  CAS  Google Scholar 

  27. Wei L, Sandbulte MR, Thomas PG, Webby RJ, Homayouni R, Pfeffer LM (2006) NFkappa B negatively regulates interferon-induced gene expression and anti-influenza activity. J Biol Chem 281(17):11678–11684

    Article  PubMed  CAS  Google Scholar 

  28. Uchide N, Toyoda H (2008) Future target molecules for influenza treatment. Mini Rev Med Chem 8(5):491–495

    Article  PubMed  CAS  Google Scholar 

  29. Chabicovsky M, Prieschl-Grassauer E, Seipelt J, Muster T, Szolar OH, Hebar A, Doblhoff-Dier O (2010) Pre-clinical safety evaluation of pyrrolidine dithiocarbamate. Basic Clin Pharmacol Toxicol 107(3):758–767

    Article  PubMed  CAS  Google Scholar 

  30. Reed LJ, Muench H (1938) A simple method of estimating fifty percent endpoints. Am J Hyg 27:493–497

    Google Scholar 

  31. Chieux V, Chehadeh W, Harvey J, Haller O, Wattre P, Hober D (2001) Inhibition of coxsackievirus B4 replication in stably transfected cells expressing human MxA protein. Virology 283(1):84–92

    Article  PubMed  CAS  Google Scholar 

  32. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate- phenol-chloroform extraction. Anal Biochem 162(1):156–159

    Article  PubMed  CAS  Google Scholar 

  33. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29(9):e45

    Article  PubMed  CAS  Google Scholar 

  34. Henke A, Launhardt H, Klement K, Stelzner A, Zell R, Munder T (2000) Apoptosis in coxsackievirus B3-caused diseases: interaction between the capsid protein VP2 and the proapoptotic protein siva. J Virol 74(9):4284–4290

    Article  PubMed  CAS  Google Scholar 

  35. Kim CH, Kim JH, Hsu CY, Ahn YS (1999) Zinc is required in pyrrolidine dithiocarbamate inhibition of NF-kappa B activation. FEBS Lett 449(1):28–32

    Article  PubMed  CAS  Google Scholar 

  36. Ulmer JB, Deck RR, DeWitt CM, Friedman A, Donnelly JJ, Liu MA (1994) Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines. Vaccine 12(16):1541–1544

    Article  PubMed  CAS  Google Scholar 

  37. Henke A (2002) DNA immunization—a new chance in vaccine research? Med Microbiol Immunol 191(3–4):187–190

    PubMed  CAS  Google Scholar 

  38. Schmidt RE (2002) Drug under test: influenza—Relenza in daily practice. Experience during the influenza season 1999/2000. Med Microbiol Immunol 191(3–4):175–179

    PubMed  CAS  Google Scholar 

  39. Harrod ME, Emery S, Dwyer DE (2006) Antivirals in the management of an influenza pandemic. Med J Aust 185(Suppl 10):S58–S61

    PubMed  Google Scholar 

  40. Monto AS, McKimm-Breschkin JL, Macken C, Hampson AW, Hay A, Klimov A, Tashiro M, Webster RG, Aymard M, Hayden FG, Zambon M (2006) Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob Agents Chemother 50(7):2395–2402

    Article  PubMed  CAS  Google Scholar 

  41. Sheu TG, Deyde VM, Okomo-Adhiambo M, Garten RJ, Xu X, Bright RA, Butler EN, Wallis TR, Klimov AI, Gubareva LV (2008) Surveillance for neuraminidase inhibitor resistance among human influenza A, B viruses circulating worldwide from 2004 to 2008. Antimicrob Agents Chemother 52(9):3284–3292

    Article  PubMed  CAS  Google Scholar 

  42. Mazur I, Wurzer WJ, Ehrhardt C, Pleschka S, Puthavathana P, Silberzahn T, Wolff T, Planz O, Ludwig S (2007) Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappa B-inhibiting activity. Cell Microbiol 9(7):1683–1694

    Article  PubMed  CAS  Google Scholar 

  43. Gaudernak E, Seipelt J, Triendl A, Grassauer A, Kuechler E (2002) Antiviral effects of pyrrolidine dithiocarbamate on human rhinoviruses. J Virol 76(12):6004–6015

    Article  PubMed  CAS  Google Scholar 

  44. Kang MS, Choi EK, Choi DH, Ryu SY, Lee HH, Kang HC, Koh JT, Kim OS, Hwang YC, Yoon SJ, Kim SM, Yang KH, Kang IC (2008) Antibacterial activity of pyrrolidine dithiocarbamate. FEMS Microbiol Lett 280(2):250–254

    Article  PubMed  CAS  Google Scholar 

  45. Krenn BM, Holzer B, Gaudernak E, Triendl A, van Kuppeveld FJ, Seipelt J (2005) Inhibition of polyprotein processing and RNA replication of human rhinovirus by pyrrolidine dithiocarbamate involves metal ions. J Virol 79(22):13892–13899

    Article  PubMed  CAS  Google Scholar 

  46. Lanke K, Krenn BM, Melchers WJ, Seipelt J, van Kuppeveld FJ (2007) PDTC inhibits picornavirus polyprotein processing and RNA replication by transporting zinc ions into cells. J Gen Virol 88(Pt 4):1206–1217

    Article  PubMed  CAS  Google Scholar 

  47. Wurzer WJ, Planz O, Ehrhardt C, Giner M, Silberzahn T, Pleschka S, Ludwig S (2003) Caspase 3 activation is essential for efficient influenza virus propagation. EMBO J 22(11):2717–2728

    Article  PubMed  CAS  Google Scholar 

  48. Erl W, Weber C, Hansson GK (2000) Pyrrolidine dithiocarbamate-induced apoptosis depends on cell type, density, and the presence of Cu2+ and Zn2+. Am J Physiol Cell Physiol 278(6):C1116–C1125

    PubMed  CAS  Google Scholar 

  49. Zabel U, Schreck R, Baeuerle PA (1991) DNA binding of purified transcription factor NF-kappa B. Affinity, specificity, Zn2+ dependence, and differential half-site recognition. J Biol Chem 266(1):252–260

    PubMed  CAS  Google Scholar 

  50. Shumilla JA, Wetterhahn KE, Barchowsky A (1998) Inhibition of NF-kappa B binding to DNA by chromium, cadmium, mercury, zinc, and arsenite in vitro: evidence of a thiol mechanism. Arch Biochem Biophys 349(2):356–362

    Article  PubMed  CAS  Google Scholar 

  51. Oxford JS, Perrin DD (1974) Inhibition of the particle-associated RNA-dependent RNA polymerase activity of influenza viruses by chelating agents. J Gen Virol 23(1):59–71

    Article  PubMed  CAS  Google Scholar 

  52. Michaelis M, Geiler J, Naczk P, Sithisarn P, Ogbomo H, Altenbrandt B, Leutz A, Doerr HW, Cinatl J Jr (2010) Glycyrrhizin inhibits highly pathogenic H5N1 influenza A virus-induced pro-inflammatory cytokine and chemokine expression in human macrophages. Med Microbiol Immunol 199:291–297

    Article  PubMed  CAS  Google Scholar 

  53. Geiler J, Michaelis M, Sithisarn P, Cinatl J Jr (2010) Comparison of pro-inflammatory cytokine expression and cellular signal transduction in human macrophages infected with different influenza A viruses. Med Microbiol Immunol. doi:10.1007/s00430-010-0173-y

  54. Julkunen I, Sareneva T, Pirhonen J, Ronni T, Melen K, Matikainen S (2001) Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression. Cytokine Growth Factor Rev 12(2–3):171–180

    Article  PubMed  CAS  Google Scholar 

  55. Geiler J, Michaelis M, Naczk P, Leutz A, Langer K, Doerr HW, Cinatl J Jr (2009) N-acetyl-L-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus. Biochem Pharmacol 79(3):413–420

    Article  PubMed  Google Scholar 

  56. Cheung CY, Poon LL, Lau AS, Luk W, Lau YL, Shortridge KF, Gordon S, Guan Y, Peiris JS (2002) Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 360(9348):1831–1837

    Article  PubMed  CAS  Google Scholar 

  57. Starko KM (2009) Salicylates and pandemic influenza mortality, 1918–1919 pharmacology, pathology, and historic evidence. Clin Infect Dis 49(9):1405–1410

    Article  PubMed  Google Scholar 

  58. Eyers S, Weatherall M, Shirtcliffe P, Perrin K, Beasley R (2010) The effect on mortality of antipyretics in the treatment of influenza infection: systematic review and meta-analysis. J R Soc Med 103(10):403–411

    Article  PubMed  Google Scholar 

Download references

Ethical standards

All experiments comply with the current laws of Germany.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Virology and Antiviral Therapy, Jena University Hospital, Friedrich Schiller University, Hans-Knöll-Str. 2, 07745, Jena, Germany

    Nadine Wiesener, Christin Zimmer, Nadine Jarasch-Althof, Peter Wutzler & Andreas Henke

Authors
  1. Nadine Wiesener
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christin Zimmer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nadine Jarasch-Althof
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Peter Wutzler
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Andreas Henke
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andreas Henke.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wiesener, N., Zimmer, C., Jarasch-Althof, N. et al. Therapy of experimental influenza virus infection with pyrrolidine dithiocarbamate. Med Microbiol Immunol 200, 115–126 (2011). https://doi.org/10.1007/s00430-010-0182-x

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00430-010-0182-x

Keywords

Search

Navigation